Morning Briefing
Summaries of health policy coverage from major news organizations
Kenya Malaria Study Shows One-Third Of Patients Receive ACTs
Just about one-third of people seeking malaria treatment in Kenya received the recommended artemisinin-based combination therapies (ACTs) and some people are being treated with ineffective drugs like chloroquine, which was phased out almost 10 years ago, according to the recently launched 2007 Kenya Malaria Indicator Survey
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
